A Stronger Path Into Europe: Nanomics Biotech Teams Up with MS Wil
June 5, 2026
Company News
Hangzhou, China and Europe — Nanomics Biotech is expanding its European commercial network through a new distribution partnership with MS Wil B.V., a Europe-based company with long-standing experience in proteomics, mass spectrometry products and customer support.
Through this partnership, MS Wil will serve as Nanomics’ European distribution partner, supporting the introduction, communication, and distribution of Nanomics’ Proteonano™ product portfolio across the European market.
For Nanomics, this collaboration is more than a channel partnership. It is part of the company’s broader effort to bring standardized, automation-ready proteomics sample preparation solutions into established mass spectrometry workflows used by research laboratories, core facilities, biotech companies, and biopharma teams.
Building a Stronger Route to European Proteomics Customers
Europe has a highly developed mass spectrometry and proteomics ecosystem, with many laboratories working across biomarker discovery, translational research, large-cohort studies, and biological data generation.
As proteomics studies become larger and more workflow-driven, sample preparation, enrichment consistency, peptide cleanup, and reproducibility are becoming increasingly important for data quality and study scalability.
By working with MS Wil, Nanomics aims to provide European customers with a more practical regional channel to learn about Proteonano™ products, discuss workflow needs, request quotations, place orders, and evaluate Nanomics solutions in their own laboratory settings.
Why MS Wil
MS Wil has long-standing experience in the mass spectrometry field and has supported specialized products used by analytical and research laboratories across Europe. This background makes MS Wil a strong regional partner for Nanomics as the company continues to expand its presence outside Asia and North America.
“We are pleased to work with MS Wil as our European distribution partner,” said Dr. Hao Wu, CEO of Nanomics Biotech. “Europe has a strong proteomics and mass spectrometry community, and this partnership will help more customers access Nanomics products and build more reproducible, scalable proteomics workflows.”
By combining Nanomics’ Proteonano™ technologies with MS Wil’s European distribution experience, both teams aim to make it easier for European laboratories to evaluate and adopt Nanomics products as part of their existing LC-MS-based proteomics workflows.
A Step Forward in Nanomics’ European Expansion
The partnership with MS Wil marks an important step in Nanomics’ continued expansion in Europe. As demand grows for standardized, scalable proteomics workflows, Nanomics will continue working with regional partners to improve product access, strengthen customer communication, and support broader adoption of Proteonano™ solutions.
Nanomics looks forward to collaborating with MS Wil and supporting more European laboratories advancing mass spectrometry-based proteomics research.
About Nanomics Biotech
Nanomics is an AI-Native biotechnology company with a vision to revolutionzie precision medicine through custom foundation model and agentic superintelligence. While the industry has mastered the genome, the functional complexity of the proteome remains the final frontier. We bridge this gap by anchoring our platform on the Proteonano HT Assay, our AI-native data generation engine designed to generate the high-fidelity data required for industrial-scale biological modeling.
This proprietary data stream powers our custom foundation model, specifically engineered to decode protein-level signals and transform biological complexity into actionable clinical intelligence. By integrating proprietary datasets with advanced AI models, we enable pharmaceutical partners to move beyond trial-and-error, providing unprecedented accuracy in clinical trial patient stratification and efficacy prediction. At Nanomics, we are building the computational bedrock for the next generation of life-saving therapies, ensuring the right medicine reaches the right patient with mathematical certainty.
Contact
Email: us@nanomics.ai Website: www.nanomics.ai
About MS Wil B.V.
MS Wil B.V. is a Europe-based company with long-standing experience in mass spectrometry products, scientific supplies, and customer support. The company supports laboratories and research customers with specialized products used in mass spectrometry and related analytical workflows.
Through its regional experience and customer network, MS Wil helps bring specialized scientific products and workflow solutions to laboratories, research institutions, and industry customers across Europe.